Drug therapy for myocarditis induced by immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs), including cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1), and its ligand 1 (PD-L1), have improved the survival in multiple types of cancers; however, ICIs may cause cardiovascular toxicity. Although rare, ICI-mediated cardiotoxicity is...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yihao, Xu, Yizhou, Xu, Linhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248045/
https://www.ncbi.nlm.nih.gov/pubmed/37305530
http://dx.doi.org/10.3389/fphar.2023.1161243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248045/
https://www.ncbi.nlm.nih.gov/pubmed/37305530
http://dx.doi.org/10.3389/fphar.2023.1161243

Ejemplares similares